StreetInsider.com News Articles

IQVIA Holdings (IQV) PT Raised to $270 at Morgan Stanley

Thu, 17 Sep 2026 07:36:50 -0400

Morgan Stanley analyst Kallum Titchmarsh raised the price target on IQVIA Holdings (NYSE: IQV) to $270.00 (from $240.00) while maintaining a Equalweight rating.

Form 8-K IQVIA HOLDINGS INC. For: Sep 09

Wed, 09 Sep 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260909/27043508.html

IQVIA prices $2 billion in senior notes due 2034

Wed, 09 Sep 2026 17:13:15 -0400

IQVIA Holdings Inc. (NYSE: IQV) announced that its wholly owned subsidiary, IQVIA Inc., has priced an offering of $2 billion in aggregate principal amount of senior notes due 2034.

The notes will carry an interest rate of 6.375% per annum, with interest paid semi-annually on March 15 and September 15 each year, beginning March 15, 2027. The notes are set to mature on March 15, 2034, unless repurchased or redeemed earlier. The issuance is expected to close on or about September 23, 2026, subject to customary closing conditions.

According to the company, proceeds from the offering will be used to redeem in

IQVIA Announces Pricing of Senior Notes

Wed, 09 Sep 2026 17:13:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering.

The Notes will bear interest at a rate of 6.375% per annum and will pay

IQVIA Announces Pricing of Senior Notes

Wed, 09 Sep 2026 17:13:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--

The Notes will bear interest at a rate of 6.375% per annum and will pay

IQVIA plans $2 billion senior notes offering due 2034

Wed, 09 Sep 2026 08:15:13 -0400

IQVIA Holdings Inc. (NYSE: IQV) announced that its wholly owned subsidiary, IQVIA Inc., intends to raise $2 billion through an offering of senior notes due 2034.

According to a press release, proceeds from the offering will be used to redeem in full the subsidiary's existing 5.000% senior notes due 2026, repay a portion of outstanding debt under its revolving credit facility, and cover fees and expenses related to the transaction. The offering is subject to market and other customary conditions.

The notes have not been registered under the Securities Act of 1933 and will be offered only to qualified institutional buyers in

IQVIA Announces Offering of Senior Notes

Wed, 09 Sep 2026 08:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the “Notes”).

The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other customary conditions.

This press release does not

IQVIA Announces Offering of Senior Notes

Wed, 09 Sep 2026 08:15:00 -0400

This press release does not

Form 4 IQVIA HOLDINGS INC. For: Sep 02 Filed by: Berkshire James G.

Fri, 04 Sep 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260904/27030547.html

IQVIA launches AI-driven clinical development platform

Thu, 03 Sep 2026 16:17:04 -0400

IQVIA (NYSE: IQV) announced the launch of IQVIA Predictive Clinical Development, an AI-powered platform aimed at helping life sciences companies reduce delays in bringing new therapies to market.

According to the company, the platform is designed to accelerate clinical trial timelines, with claimed performance metrics including 33% faster study startup, 1.7 times more patients recruited from AI-prioritized sites, 50% faster data cleaning, and a 45% or greater reduction in time between trial phases.

The platform incorporates technology from several third-party providers, including Anthropic, Amazon Web Services, Databricks, Microsoft, Nvidia, Palantir, and Snowflake, alongside IQVIA's proprietary data and regulatory expertise.

The platform consists of

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

Thu, 03 Sep 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.

Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results:

33% faster study startup
1.7 times more patients recruited from our AI prioritized and Prime & Partner sites

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

Thu, 03 Sep 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.
Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical Development is built to eliminate them, accelerating every stage of the development lifecycle with measurable results:

33% faster study startup

1.7 times more patients recruited from our AI prioritized and Prime & Partner sites

Form 144 IQVIA HOLDINGS INC. Filed by: Berkshire James G.

Wed, 02 Sep 2026 16:12:00 -0400
si-local-file:///var/storage/secattach/20260902/27019111.html

IQVIA Holdings (IQV) PT Raised to $300 at HSBC

Tue, 01 Sep 2026 02:16:49 -0400
HSBC analyst Shubhangi Gupta raised the price target on IQVIA Holdings (NYSE: IQV) to $300.00 (from $280.00) while maintaining a Buy rating.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.

IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare

Thu, 27 Aug 2026 16:15:00 -0400

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
Healthcare and life sciences organizations are under growing pressure to bring therapies to patients faster, make sense of rapidly expanding volumes of data and adopt AI they can trust.